Clinical Report: Immunomodulatory Approaches for Pneumonia Related to Stroke

Overview

This review highlights the immunopathology of stroke-associated pneumonia (SAP) and evaluates immune-targeted strategies based on findings from 38 studies, indicating stroke-induced immunosuppression as a key factor in SAP development.

Background

Stroke is a leading cause of death and disability worldwide, with a significant risk of post-stroke infections, particularly pneumonia. Approximately 30% of acute stroke patients develop infections, with pneumonia rates reaching 10%, contributing to increased mortality. Understanding the immune dysregulation following stroke is crucial for developing effective prevention and treatment strategies for SAP.

Data Highlights

No numerical data or trial results are provided in the source material.

Key Findings

• Stroke severity disrupts immune homeostasis, leading to SAP through a complex network.
• Systemic immunosuppression is primarily driven by sympathetic nervous system overactivation, resulting in splenic atrophy and lymphocyte apoptosis.
• Active intercellular suppression, such as monocyte-mediated T cell death, compromises immunity further.
• Disruption of the gut-lung axis and local pulmonary alterations are implicated in SAP development.
• Immunomodulatory interventions, like iNKT cell activators, show promise in preclinical models.

Clinical Implications

Targeting immune mechanisms may provide new avenues for preventing and treating SAP, but most strategies remain experimental and require further validation.

Conclusion

This review highlights the need for continued research into immunomodulatory therapies for SAP, as current treatment options are limited and understanding the underlying mechanisms is essential for future developments.

Related Resources & Content

1. Frontiers in Immunology, 2026 -- Beyond the usual suspects: rethinking post-stroke immunosuppression
2. Acta Neuropathologica, 2018 -- Inflammation Following Stroke: A Potential Therapeutic Target or a Beneficial Mechanism?
3. Frontiers in Immunology, 2026 -- Targeting T cell metabolism and polarization to modulate post-stroke immune responses and improve outcomes
4. Intensive Care Medicine, 2023 -- An Introduction to Targeted Immunomodulation for Critical Care Physicians
5. European Stroke Journal, 2026 -- 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke
6. 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association
7. https://academic.oup.com/esj/article/11/5/aakag044/8671383?login=true&preview=true
8. 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association